{{Rsnum
|rsid=4760674
|Gene=TMEM106C
|Chromosome=12
|position=47963231
|Orientation=plus
|GMAF=0.2392
|Gene_s=TMEM106C
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 19.5 | 41.6 | 38.9
| HCB | 0.0 | 3.6 | 96.4
| JPT | 0.0 | 0.0 | 100.0
| YRI | 6.8 | 42.9 | 50.3
| ASW | 5.3 | 31.6 | 63.2
| CHB | 0.0 | 3.6 | 96.4
| CHD | 0.0 | 6.5 | 93.5
| GIH | 4.0 | 42.6 | 53.5
| LWK | 2.7 | 32.7 | 64.5
| MEX | 6.9 | 24.1 | 69.0
| MKK | 3.2 | 33.3 | 63.5
| TSI | 13.7 | 53.9 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21365644
|Title=Vitamin D receptor polymorphisms in patients with cutaneous melanoma
|OA=1
}}

{{PMID Auto
|PMID=19454612
|Title=Vitamin D pathway gene variants and prostate cancer risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}